Describing Assay Precision—Reciprocal of Variance Is Correct, Not CV Percent: Its Use Should Significantly Improve Laboratory Performance
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Describing assay error as percent coefficient of variation (CV%) fails as measurements approach zero. Results are censored if below some arbitrarily chosen lower limit of quantification (LLOQ). CV% gives incorrect weighting to data obtained by therapeutic drug monitoring, with incorrect parameter values in the resulting pharmacokinetic models, and incorrect dosage regimens for patient care. METHODS: CV% was compared with the reciprocal of the variance (1/var) of each assay measurement. This method has not been considered by the laboratory community. A simple description of assay standard deviation (SD) as a polynomial function of the assay measurement over its working range was developed, the reciprocal of the assay variance determined, and its results compared with CV%. RESULTS: CV% does not provide correct weighting of measured serum concentrations as required for optimal therapeutic drug monitoring. It does not permit optimally individualized models of the behavior of a drug in a patient, resulting in incorrect dosage regimens. The assay error polynomial described here, using 1/var, provides correct weighting of such data, all the way down to and including zero. There is no need to censor low results, and no need to set any arbitrary LLOQ. CONCLUSIONS: Reciprocal of variance is the correct measure of assay precision and should replace CV%. The information is easily stored as an assay error polynomial. The laboratory can serve the medical community better. There is no longer any need for LLOQ, a significant improvement. Regulatory agencies should implement this more informed policy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“far beyond acceptable levels for an industrial environment (ideally < 20%)20”
From Examining iPSC derived motor neuron variability and genome stability monitoring as a solution (2025) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Ways to Fit a PK Model with Some Data Below the Quantification Limit
Beal, S. L. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1012299115260 · Cited by 1,114
Handling Data Below the Limit of Quantification in Mixed Effect Models
Bergstrand, M., & Karlsson, M. O. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9112-5 · Cited by 335
Optimal sampling times for pharmacokinetic experiments
D'Argenio, D. Z. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01070904 · Cited by 324
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Neely, M., Rushing, T., Kovacs, A., Jelliffe, R., & Hoffman, J. (2010) · Clinical Infectious Diseases · doi:10.1086/648679 · Cited by 214
Self-citationJelliffe, R. W., Schumitzky, A., Guilder, M. V., Liu, M., Hu, L. H., Maire, P. H., Gomis, P., Barbaut, X., & Tahani, B. (1993) · PubMed · Cited by 149
Self-citationIndividualizing Drug Dosage Regimens
Jelliffe, R. W., Schumitzky, A., Guilder, M. V., Liu, M., Hu, L., Maire, P. H., Gomis, P., Barbaut, X., & Tahani, B. (1993) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199310000-00005 · Cited by 139
Self-citationDecosterd, L. A., Rochat, B., Pesse, B., Mercier, T., Tissot, F., Widmer, N., Bille, J., Calandra, T., Zanolari, B., & Marchetti, O. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00404-10 · Cited by 121
Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS
Alffenaar, J. C., Wessels, A. M. A., van Hateren, K., Greijdanus, B., Kosterink, J. G. W., & Uges, D. R. A. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.11.017 · Cited by 109
Larsson, A. J., Walker, K. J., Raddatz, J. K., & Rotschafer, J. C. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.4.589 · Cited by 105
Research works printed but not linked: 2
- DeGroot M Probability and Statistics 1989 403 423 Addison-Wesley Reading MA 2nd ed
- Seber G Wild C Nonlinear regression 1989 536 37 Wiley New York
Cited by
Raney, S. G., Franz, T., Lehman, P. A., Lionberger, R. A., & Chen, M. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0292-0 · Cited by 90
Nonparametric Methods in Population Pharmacokinetics
Goutelle, S., Woillard, J., Neely, M. N., Yamada, W. M., & Bourguignon, L. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1650 · Cited by 64
Self-citationIn Situ Single‐Cell Western Blot on Adherent Cell Culture
Zhang, Y., Naguro, I., & Herr, A. E. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201906920 · Cited by 48
Lee, J., Abdulhafez, M., & Bedewy, M. (2019) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.9b07894 · Cited by 30
Shashar, S., Ellen, M., Codish, S., Davidson, E., & Novack, V. (2021) · The Annals of Family Medicine · doi:10.1370/afm.2627 · Cited by 22
Metadata
- Authors
- Jelliffe, R. W., Schumitzky, A., Bayard, D., Fu, X., & Neely, M.
- Affiliations
- University of Southern California (US)
- Children's Hospital Los Angeles (US)
- Corresponding author
- Jelliffe, Roger W.
- Venue
- Therapeutic Drug Monitoring
- Published
- 2015-06
- Volume
- 37
- Issue
- 3
- Pages
- 389-394
- ISSN
- 0163-4356 (ISSN-L)
- PMC
- PMC4435937
- OpenAlex
- W2416580215
- Cited by
- 47
- References
- 12
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 9 · 2023: 2 · 2022: 8 · 2021: 5 · 2020: 2 · 2019: 7 · 2018: 1 · 2016: 1 · 2015: 1
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Therapeutic Drug Monitoring (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM068968, GM068968)
- National Institute of Biomedical Imaging and Bioengineering (R01EB005803, EB005803)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD070996, R01HD070996)
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
- Physical Sciences › Physics and Astronomy › Instrumentation › Scientific Measurement and Uncertainty Evaluation
- Keywords
- assay precision, coefficient of variation, lower limit of quantification, censored data, pharmacokinetic modeling, dosing regimen
- MeSH terms
- Data Accuracy, Blood Chemical Analysis, Humans, Models, Statistical, Drug Monitoring, Limit of Detection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Describing Assay Precision—Reciprocal of Variance Is Correct, Not CV Percent: Its Use Should Significantly Improve Laboratory Performance. https://app.cochat.ai/papers/10.1097/ftd.0000000000000168
- The paper
- Jelliffe, R. W., Schumitzky, A., Bayard, D., Fu, X., & Neely, M. (2015). Describing Assay Precision—Reciprocal of Variance Is Correct, Not CV Percent: Its Use Should Significantly Improve Laboratory Performance. Therapeutic Drug Monitoring. https://doi.org/10.1097/ftd.0000000000000168
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.